Analystreport

CELLECT BIOTECH/S (NASDAQ: APOP) was given a new $14.00 price target on by analysts at HC Wainwright. They now have a "buy" rating on the stock.

Cellect Biotechnology Ltd. - American Depositary Shares  (APOP) 
US:NASDAQ Investor Relations: cellect.co